PharmaBoardroom

Speaking exclusively to PharmaBoardroom, Lundbeck’s global CEO Deborah Dunsire describes the progress in the strategy she put in place to…

CEO Tero Silvola introduces BC Platforms’ powerful data and technology platform for personalized medicine and drug development and the ‘infinity…

Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in oncology R&D at Novartis and…

In an exclusive interview, Jean-Paul Clozel explains Idorsia's unique value proposition as a biotech focused on small molecules, how agnosticism in…

In a wide-ranging and exclusive interview with PharmaBoardroom, Ipsen CEO David Loew looks back on an atypical first 100 days at the helm of the…

In 2019 PharmaBoardroom had the exclusive opportunity to speak with executives that are heading up some of European pharma's top companies. These…

Gábor Orbán, CEO of Gedeon Richter, highlights the recent turnaround of the company's performance, its exciting new collaboration with Allergan in…

István Hodász, CEO of Egis Pharmaceuticals PLC, introduces the longstanding history of the company and its positioning as a leading manufacturer of…

2018 has been an exciting year in world health and our team has spanned the globe to bring you in-depth country reports and high profile interviews…

Geoffrey Guy, David Meek, Tae Han Kim, Pierre Moustial, Vivek Sharma, Antonio Portela and many other remarkable people that are shaping the global…

Actelion’s global CEO and co-founder, Dr. Jean-Paul Clozel, discusses diversifying the company’s portfolio, prioritizing internal research over…